Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2011-07-05

FDA Approved: ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Taro Pharmaceuticals U.S.A., Inc.)

View source ↗

Summary

The FDA approved a supplemental application for a generic fixed-dose combination of enalapril maleate and hydrochlorothiazide by Taro Pharmaceuticals U.S.A., In…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Enalaprilate and Hydrochlorothiazide (Enalapril maleate and hydrochlorothiazide)

Snippet

SUPPL AP for ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE (ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE)